Prominence of Microbiota to Predict Fibrous Stenosis in Crohn’s Disease

Xue Yang,* Yan Pan,* Cai-Ping Gao, Hang Li, Ying-Hui Zhang, Chun-Li Huang, Lu Cao, Shi-Yu Xiao, Zhou Zhou Department of Gastroenterology, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People’s Republic of...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang X, Pan Y, Gao CP, Li H, Zhang YH, Huang CL, Cao L, Xiao SY, Zhou Z
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Journal of Inflammation Research
Subjects:
Online Access:https://www.dovepress.com/prominence-of-microbiota-to-predict-fibrous-stenosis-in-crohns-disease-peer-reviewed-fulltext-article-JIR
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825208907219337216
author Yang X
Pan Y
Gao CP
Li H
Zhang YH
Huang CL
Cao L
Xiao SY
Zhou Z
author_facet Yang X
Pan Y
Gao CP
Li H
Zhang YH
Huang CL
Cao L
Xiao SY
Zhou Z
author_sort Yang X
collection DOAJ
description Xue Yang,&ast; Yan Pan,&ast; Cai-Ping Gao, Hang Li, Ying-Hui Zhang, Chun-Li Huang, Lu Cao, Shi-Yu Xiao, Zhou Zhou Department of Gastroenterology, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Zhou Zhou; Shi-Yu Xiao, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China, Email doublezhouu2006@163.com; xiaoshiyu57@163.comPurpose: Intestinal fibrous stenosis due to Crohn’s disease (CD) is highly prevalent. Although several clinical risk factors for fibrous stenosis have been identified, such as perianal fistulizing disease, small bowel disease location, and deep mucosal ulceration, predicting fibrous stenosis remains challenging. The intestinal microbiota plays a crucial role in the development and progression of CD. However, its role in intestinal fibrous stenosis is poorly understood. Leveraging a single-center cross-sectional study, we aimed to investigate the role of fecal microbiota in CD-associated fibrous stenosis.Methods: Using metagenomic analysis, we examined the differences in fecal microbiota between CD patients with intestinal fibrous stenosis and those without stenosis. We identified specific microbiota and assessed their predictive accuracy for intestinal fibrous stenosis. Additionally, we explored functional differences in intestinal microbiota between the two groups.Results: : Our investigation of fecal samples revealed no significant differences in the gut microbiota structure between patients with fibrous stenosis and those without stenosis in CD. However, taxonomically, we found 70 taxa with significantly different abundance (p < 0.05) between the two groups. Furthermore, LEfSe analysis indicated that g_Bacteroides and g_Enterocloster could predict intestinal fibrous stenosis while p_Actinobacteria, c_Actinomycetia, c_Bacilli, o_Lactobacillales, f_Streptococcaceae and g_Streptococcus could predict CD without stenosis. Functional analysis revealed differential enrichment in five metabolic pathways at the KEGG pathway level in CD patients with fibrous stenosis, including sphingolipid metabolism, lipoic acid metabolism, and biosynthesis of neomycin, kanamycin and gentamicin. In the eggNOG database, we observed differences in four functional categories between the two groups, encompassing cellular process, signaling, and metabolism.Conclusion: Fecal microbiota significantly impacted intestinal fibrous stenosis in CD. Although there were no significant differences in alpha and beta diversities, fibrous stenosis was associated with changes in microbiota composition and function, suggesting the potential of fecal microbiota in predicting CD-associated fibrous stenosis.Keywords: Crohn’s disease, fibrous stenosis, fecal microbiota, metagenomic analysis
format Article
id doaj-art-fdcd109f45b1413b81ce37cce60ae345
institution Kabale University
issn 1178-7031
language English
publishDate 2025-02-01
publisher Dove Medical Press
record_format Article
series Journal of Inflammation Research
spelling doaj-art-fdcd109f45b1413b81ce37cce60ae3452025-02-06T16:40:24ZengDove Medical PressJournal of Inflammation Research1178-70312025-02-01Volume 181413142399900Prominence of Microbiota to Predict Fibrous Stenosis in Crohn&rsquo;s DiseaseYang XPan YGao CPLi HZhang YHHuang CLCao LXiao SYZhou ZXue Yang,&ast; Yan Pan,&ast; Cai-Ping Gao, Hang Li, Ying-Hui Zhang, Chun-Li Huang, Lu Cao, Shi-Yu Xiao, Zhou Zhou Department of Gastroenterology, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Zhou Zhou; Shi-Yu Xiao, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China, Email doublezhouu2006@163.com; xiaoshiyu57@163.comPurpose: Intestinal fibrous stenosis due to Crohn’s disease (CD) is highly prevalent. Although several clinical risk factors for fibrous stenosis have been identified, such as perianal fistulizing disease, small bowel disease location, and deep mucosal ulceration, predicting fibrous stenosis remains challenging. The intestinal microbiota plays a crucial role in the development and progression of CD. However, its role in intestinal fibrous stenosis is poorly understood. Leveraging a single-center cross-sectional study, we aimed to investigate the role of fecal microbiota in CD-associated fibrous stenosis.Methods: Using metagenomic analysis, we examined the differences in fecal microbiota between CD patients with intestinal fibrous stenosis and those without stenosis. We identified specific microbiota and assessed their predictive accuracy for intestinal fibrous stenosis. Additionally, we explored functional differences in intestinal microbiota between the two groups.Results: : Our investigation of fecal samples revealed no significant differences in the gut microbiota structure between patients with fibrous stenosis and those without stenosis in CD. However, taxonomically, we found 70 taxa with significantly different abundance (p < 0.05) between the two groups. Furthermore, LEfSe analysis indicated that g_Bacteroides and g_Enterocloster could predict intestinal fibrous stenosis while p_Actinobacteria, c_Actinomycetia, c_Bacilli, o_Lactobacillales, f_Streptococcaceae and g_Streptococcus could predict CD without stenosis. Functional analysis revealed differential enrichment in five metabolic pathways at the KEGG pathway level in CD patients with fibrous stenosis, including sphingolipid metabolism, lipoic acid metabolism, and biosynthesis of neomycin, kanamycin and gentamicin. In the eggNOG database, we observed differences in four functional categories between the two groups, encompassing cellular process, signaling, and metabolism.Conclusion: Fecal microbiota significantly impacted intestinal fibrous stenosis in CD. Although there were no significant differences in alpha and beta diversities, fibrous stenosis was associated with changes in microbiota composition and function, suggesting the potential of fecal microbiota in predicting CD-associated fibrous stenosis.Keywords: Crohn’s disease, fibrous stenosis, fecal microbiota, metagenomic analysishttps://www.dovepress.com/prominence-of-microbiota-to-predict-fibrous-stenosis-in-crohns-disease-peer-reviewed-fulltext-article-JIRcrohn’s diseasefibrous stenosisfecal microbiotametagenomic analysis
spellingShingle Yang X
Pan Y
Gao CP
Li H
Zhang YH
Huang CL
Cao L
Xiao SY
Zhou Z
Prominence of Microbiota to Predict Fibrous Stenosis in Crohn&rsquo;s Disease
Journal of Inflammation Research
crohn’s disease
fibrous stenosis
fecal microbiota
metagenomic analysis
title Prominence of Microbiota to Predict Fibrous Stenosis in Crohn&rsquo;s Disease
title_full Prominence of Microbiota to Predict Fibrous Stenosis in Crohn&rsquo;s Disease
title_fullStr Prominence of Microbiota to Predict Fibrous Stenosis in Crohn&rsquo;s Disease
title_full_unstemmed Prominence of Microbiota to Predict Fibrous Stenosis in Crohn&rsquo;s Disease
title_short Prominence of Microbiota to Predict Fibrous Stenosis in Crohn&rsquo;s Disease
title_sort prominence of microbiota to predict fibrous stenosis in crohn rsquo s disease
topic crohn’s disease
fibrous stenosis
fecal microbiota
metagenomic analysis
url https://www.dovepress.com/prominence-of-microbiota-to-predict-fibrous-stenosis-in-crohns-disease-peer-reviewed-fulltext-article-JIR
work_keys_str_mv AT yangx prominenceofmicrobiotatopredictfibrousstenosisincrohnrsquosdisease
AT pany prominenceofmicrobiotatopredictfibrousstenosisincrohnrsquosdisease
AT gaocp prominenceofmicrobiotatopredictfibrousstenosisincrohnrsquosdisease
AT lih prominenceofmicrobiotatopredictfibrousstenosisincrohnrsquosdisease
AT zhangyh prominenceofmicrobiotatopredictfibrousstenosisincrohnrsquosdisease
AT huangcl prominenceofmicrobiotatopredictfibrousstenosisincrohnrsquosdisease
AT caol prominenceofmicrobiotatopredictfibrousstenosisincrohnrsquosdisease
AT xiaosy prominenceofmicrobiotatopredictfibrousstenosisincrohnrsquosdisease
AT zhouz prominenceofmicrobiotatopredictfibrousstenosisincrohnrsquosdisease